Abstract: A liquid crystal display apparatus includes a display panel, a light source module configured to provide light to the display panel, a receiving container receiving the light source module therein, and an adhesion member disposed between the display panel and the receiving container to couple the display panel to the receiving container. The adhesion member includes a base layer with a hollow pocket therein and an adhesion layer disposed on both surface of the base layer. When the display panel is deformed, the adhesion member conforms thereto. Thus, light-leakage of the display panel may be prevented and light characteristics of the liquid crystal display apparatus may be improved.

Abstract: A liquid crystal display apparatus includes a display panel, a light source module configured to provide light to the display panel, a receiving container receiving the light source module therein, and an adhesion member disposed between the display panel and the receiving container to couple the display panel to the receiving container. The adhesion member includes a base layer with a hollow pocket therein and an adhesion layer disposed on both surface of the base layer. When the display panel is deformed, the adhesion member conforms thereto. Thus, light-leakage of the display panel may be prevented and light characteristics of the liquid crystal display apparatus may be improved.

Abstract: A display device includes a display panel including a gate line, a data line, and a pixel connected to the gate line and the data line, a signal controller generating control signals for driving the display panel including a data load timing signal, a gate driver applying a gate voltage to the gate line, and a data driver applying a data voltage to the data line according to the data load timing signal received from the signal controller, wherein the data load timing signal includes a first load signal pulse and a different second load signal pulse, and where a width of the second load signal pulse is larger than a width of the first load signal pulse.

Abstract: The present invention relates to a medicinal composition for preventing or treating pancreatic cancer, comprising 3-alkoxy-6-allylthiopyridazine or a pharmaceutically acceptable salt thereof as an effective ingredient. An MTT assay, to assess the viability of cells, and flow cytometric analysis, to measure apoptotic cell death, were performed, and the results, which revealed that the compound and pharmaceutically acceptable salts thereof have preventive and therapeutic activity against pancreatic cancer, are presented herein.

Abstract: The, present invention relates to a novel allylthiopyridazine derivative represented by formula (I) which exhibits a superior effect for prevention and treatment or hepatic diseases induced by toxic substances and for protection of human tissues from radiation: ##STR1## or a pharmaceutically acceptable salt thereof, in which R.sub.1 represents halogen atom, lower alkoxy, dialkylaminoalkoxy, hydroxyalkoxy, phenoxy substituted or unsubstituted with lower alkyl, benzyloxy, or phenyl, andR.sub.2 and R.sub.3 independently of one another represent hydrogen or lower alkyl, or R.sub.2 and R.sub.3 together with carbon atom to which they are attached can form a saturated or unsaturated 6-membered ring,provided that R.sub.2 and R.sub.3 are other than hydrogen when R.sub.1 is chloro; and to a process for preparing thereof and a pharmaceutical composition containing the same as an effective component.